Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
633.00    13.00 (2.10%)
Bid:
635.00
Ask:
636.00
Spread: 1.00 (0.157%)
Market Cap: £551.50m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Directorate Change

29 Sep 2015 16:19

RNS Number : 6078A
Victrex PLC
29 September 2015
Β 

ο»Ώ

29 September 2015

Victrex plc - Directorate Change

Β 

Notification in accordance with Listing Rule 9.6.11R

Β 

Directorate Change

Victrex plc today announces that Giles Kerr will stand down from the Board as Non-executive Director of Victrex plc and Chairman of the Audit Committee, effective 30 September 2015 after 9 years' service.

Andrew Dougal, an existing Non-executive Director of the Board, will become Chairman of the Audit Committee, effective 1 October 2015.

Enquiries

Victrex plc

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 7809 595831

Β 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the strategic markets of Automotive, Aerospace, Electronics, Energy and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are delivering leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAEASNNAFXSEFF
Date   Source Headline
19th Dec 20121:09 pmRNSDirector/PDMR Shareholding
18th Dec 20124:40 pmRNSDirector/PDMR Shareholding
18th Dec 201210:08 amRNSHolding(s) in Company
12th Dec 20124:08 pmRNSDirector/PDMR Shareholding
11th Dec 20127:00 amRNSFinal Results
3rd Dec 20122:23 pmRNSBlocklisting Interim Review
30th Nov 20122:05 pmRNSTotal Voting Rights
20th Nov 201212:18 pmRNSDirector/PDMR Shareholding
1st Nov 201210:34 amRNSTotal Voting Rights
30th Oct 201210:28 amRNSHolding(s) in Company
18th Oct 20124:07 pmRNSDirector/PDMR Shareholding
16th Oct 201212:03 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSSite Visit
10th Oct 201210:33 amRNSHolding(s) in Company
4th Oct 20127:00 amRNSTrading Statement
28th Sep 20121:36 pmRNSTotal Voting Rights
28th Sep 20121:21 pmRNSHolding(s) in Company
19th Sep 201212:57 pmRNSDirector/PDMR Shareholding
31st Aug 20122:05 pmRNSTotal Voting Rights
20th Aug 201211:22 amRNSDirector/PDMR Shareholding
31st Jul 201212:19 pmRNSTotal Voting Rights
26th Jul 20127:00 amRNSInterim Management Statement
17th Jul 20123:35 pmRNSDirector/PDMR Shareholding
12th Jul 201210:41 amRNSHolding(s) in Company
29th Jun 20122:25 pmRNSTotal Voting Rights
27th Jun 20123:48 pmRNSDirector/PDMR Shareholding
20th Jun 20123:10 pmRNSDirector/PDMR Shareholding
14th Jun 20121:23 pmRNSDirector/PDMR Shareholding
1st Jun 201211:44 amRNSBlocklisting Interim Review
31st May 20122:55 pmRNSTotal Voting Rights
22nd May 20127:00 amRNSHalf Yearly Report
17th May 20123:52 pmRNSDirector/PDMR Shareholding
30th Apr 20124:26 pmRNSTotal Voting Rights
27th Apr 20127:00 amRNSManagement Change
26th Apr 20128:30 amRNSAdditional Listing
18th Apr 20124:10 pmRNSDirector/PDMR Shareholding
5th Apr 20127:00 amRNSTrading Update
30th Mar 201212:11 pmRNSTotal Voting Rights
26th Mar 201211:45 amRNSHolding(s) in Company
19th Mar 20123:06 pmRNSDirector/PDMR Shareholding
19th Mar 20127:00 amRNSManagement Change
29th Feb 20122:11 pmRNSTotal Voting Rights
20th Feb 201211:52 amRNSDirector/PDMR Shareholding
17th Feb 201210:39 amRNSHolding(s) in Company
13th Feb 201211:37 amRNSHolding(s) in Company
9th Feb 20123:25 pmRNSHolding(s) in Company
8th Feb 201210:33 amRNSResult of AGM
7th Feb 20127:00 amRNSAGM and Interim Management Statement
31st Jan 20123:02 pmRNSTotal Voting Rights
17th Jan 20123:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.